Determination of salmeterol, α ‐hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC–QTOF

Determination of salmeterol, α ‐hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC–QTOF–MS

Published:2021-04-11 Issue:8 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Sakellariou Panagiotis¹²,Petrou Michael³⁴^ORCID,Lyris Emmanouil¹,Tsivou Maria⁵,Fragkaki Argyro¹,Kiousi Polyxeni¹,Angelis Yiannis S.¹,Pistos Constantinos⁶^ORCID

Affiliation:

1. Doping Control Laboratory of Athens, Institute of Biosciences and Applications National Centre for Scientific Resarch “Demokritos” Maroussi Greece

2. Faculty of Biology, School of Science National and Kapodistrian University of Athens Athens Greece

3. Cyprus Anti‐Doping Authority Nicosia Cyprus

4. University of Nicosia Nicosia Cyprus

5. Dopingkontroll‐Labor Chemical Analytics Seibersdorf Labor GmbH Seibersdorf Austria

6. Department of Chemistry West Chester University of Pennsylvania West Chester PA USA

Funder

World Anti-Doping Agency

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5114

Reference19 articles.

1. Responses to bronchial challenge submitted for approval to use inhaled β2-agonists before an event at the 2002 winter olympics

2. A rapid and sensitive HPLC–APCI-MS/MS method determination of fluticasone in human plasma: Application for a bioequivalency study in nasal spray formulations

3. Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography–tandem mass spectrometry

4. Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration levels

5. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution;Environmental Toxicology and Pharmacology;2024-06

2. A New HPLC-Fluorescence Method for the Simultaneous Determination of Fluticasone Propionate and Salmeterol Xinafoate in Their Solutions Involving Schiff-Base Derivatization with Hydrazine;Jordan Journal of Chemistry;2024-04-30

3. Rapid determination of 48 stimulant residues in milk and dairy products by high-performance liquid chromatography coupled with quadrupole/Orbitrap high-resolution mass spectrometry;Chemical Papers;2023-05-19

4. Annual banned‐substance review: Analytical approaches in human sports drug testing 2020/2021;Drug Testing and Analysis;2021-11-23